SCHEMBL21067665

SCHEMBL21067665

Oc1ccc2c(-c3cccc(Br)c3)noc2c1

nearest known ligand 0.66

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 20/20 0.66
ESR2 Q92731 20/20 0.66
HSP90AA1 P07900 3/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8483557 0.83 ESR1 (0.81) ESR1ESR2HSP90AA1
SCHEMBL14020898 0.83 ESR1 (0.81) ESR1ESR2HSP90AA1
SCHEMBL4219293 0.80 ESR1 (0.76) ESR1ESR2HSP90AA1
SCHEMBL3935834 0.79 ESR1 (1.00) ESR1ESR2HSP90AA1
SCHEMBL3922447 0.79 ESR1 (1.00) ESR1ESR2HSP90AA1
SCHEMBL3925168 0.77 ESR1 (1.00) ESR1ESR2HSP90AA1
SCHEMBL3930795 0.77 ESR1 (1.00) ESR1ESR2HSP90AA1
SCHEMBL5374819 0.77 ESR1 (0.58) ESR1ESR2HSP90AA1
SCHEMBL7548059 0.75 ESR1 (0.66) ESR1ESR2HSP90AA1
SCHEMBL3935768 0.75 ESR1 (1.00) ESR1ESR2HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11446398-B2 Regulated biocircuit systems OBSIDIAN THERAPEUTICS, INC. (US) 2022-09-20 US disclosed
US-20190192691-A1 REGULATED BIOCIRCUIT SYSTEMS OBSIDIAN THERAPEUTICS, INC. 2019-06-27 US disclosed